BG
BGM Group Ltd.
BGM · NASDAQ
$0.26 +5.77% (+$0.01)
1M +2.24%
Market Cap $100.4M
P/E Ratio -
Div. Yield -
ROE 0.88%
Bulios Fair Price
$0.14
46.9% downside
Current Price
$0.26
Undervalued Fair Value Overvalued
According to Bulios Fair Price, BGM is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Valuation
28 /100
Expensive P/S 4.00x
P/B 2.35x
EV/EBITDA 102.96x
Growth
0 /100
Declining Book val. growth 7.98%
Rev. growth 23.97%
FCF growth N/A
Profitability
4 /100
Weak Net margin 5.75%
Op. margin 2.25%
FCF margin 13.50%
Quality
6 /100
Poor ROE 0.88%
ROA 2.72%
Asset turnover 0.47x
Debt
80 /100
Low Current ratio 3.39x
Int. coverage -0.56x
Net debt/EBITDA -11.16x
Stability
11 /100
Unstable Rev. volatility 30.60%
EPS volatility 483.41%
Profitable years 0
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about BGM
Online
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Chen Xin
Employees
298
Headquarters
Chengdu